Free Newsletter
Hedge fund managers dangle million-dollar research prize
A Harvard Medical School researcher has joined with two New York hedge funds to create a new million-dollar annual award for the best new thinking in cancer research. Harvard's Gary Curhan says the Gotham Prize is intended to spur scientists to share their ideas on cancer research. Winners of the award will be allowed to use the money for anything they want. Entrants will post their ideas on the group's Web site and the organizers hope that institutions and others will use the site to find research projects that have been unable to attract government funding. Hedge fund managers Joel Greenblatt and Robert Goldstein say that the same cash-prize approach has worked well in the business world and could inspire progress in the scientific community as well.
- see the release on the prize
- check out the report on the prize from the The Star-Ledger
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: